Ignite Creation Date:
2024-05-05 @ 5:36 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00492505
Status:
UNKNOWN
Last Update Posted:
2014-01-10
First Post:
2007-06-25
Brief Title:
Sorafenib Tamoxifen and Cisplatin in Treating Patients With High-Risk Stage III Melanoma
Sponsor:
San Diego Pacific Oncology Hematology Associates
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
CDR0000551556
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
San Diego Pacific Oncology Hematology Associates
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None